Risa Cretella - 11 May 2023 Form 4 Insider Report for Sovos Brands, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 May 2023, 16:30:28 UTC
Prior SEC filing
05 Apr 2023
Next SEC filing
18 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Isobel A. Jones, Attorney-in-Fact

Key filing fact

Risa Cretella filed Form 4 for Sovos Brands, Inc. on 12 May 2023.

Key facts

  • This page summarizes Risa Cretella's Form 4 filing for Sovos Brands, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 May 2023, 16:30.

Change

  • Previous filing in this sequence was filed on 05 Apr 2023.
  • Current net transaction value: -$237,949.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SOVO transaction

Common Stock

Sale

Transaction value
$225,858
Shares
-11,582
Change %
-4.1%
Price
$19.50
Shares after
269,704
Date
11 May 2023
Ownership
Direct
Footnotes
F1, F2, F3
SOVO transaction

Common Stock

Sale

Transaction value
$12,090
Shares
-600
Change %
-0.22%
Price
$20.15
Shares after
269,104
Date
11 May 2023
Ownership
Direct
Footnotes
F1, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This transaction was effected pursuant to a written plan that was adopted by the Reporting Person on September 8, 2022 prior to the SEC's adoption of amendments to Rule 10b5-1 of the Exchange Act in December 2022 and was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) as in effect at the time of adoption. The plan was structured to include several sale periods and was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.08 to $20.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any stockholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Includes 47,055 restricted shares of common stock of the Issuer subject to time-based vesting and the Reporting Person's continued service with the Issuer (a portion of which will vest on December 30,2023, September 23, 2024 or September 23, 2025, if original performance goals are not earlier achieved), 67,508 restricted shares of common stock of the Issuer subject to performance-based vesting and the Reporting Person's continued service with the Issuer, and 90,751 restricted stock units subject to time-based vesting, subject to the terms of the applicable award agreement.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.09 to $20.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any stockholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .